Clinical Significance of Helicobacter Pylori Infection and Interleukin-1 Polymorphism with Acute Myocardial Infarction

Clinical Significance of Helicobacter Pylori Infection and Interleukin-1 Polymorphism with Acute Myocardial Infarction - Clinical Significance of Helicobacter Pylori Infection and Interleukin-1 Polymorphism with Acute Myocardial Infarction

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016482

Enrollment

200

Registered

2015-02-09

Start date

2009-01-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: We registered patients who were admitted to Kumamoto University Hospital for acute myocardial infarction and who did not have atherosclerotic diseases

Exclusion criteria

Exclusion criteria: 1. end-stage renal disease on hemodialysis 2. severe liver dysfunction 3. malignant disease with severe prognosis 4. other inflammatory disease 5. severe sickness

Design outcomes

Primary

Measure	Time frame
The prevalence of Helicobacter pylori infection and interleukin-1 polymorphisms in patients with acute myocardial infarction	—

Secondary

Measure	Time frame
Inflammation Peripheral endothelial function	—

Countries

Japan

Contacts

Public ContactSeiji Hokimoto

Graduate School of Medical Sciences, Kumamoto University Department of Cardiovascular Medicine

shokimot@kumamoto-u.ac.jp096-373-5175

Outcome results